# Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease

> **NCT05322057** · — · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 14 (actual)

## Conditions studied

- Crohn Disease
- Fistula Perianal

## Interventions

- **DRUG:** Darvadstrocel

## Key facts

- **NCT ID:** NCT05322057
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322057, "Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05322057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*